Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

D-chiro-inositol glycans in insulin signaling and insulin resistance.

Larner J, Brautigan DL, Thorner MO.

Mol Med. 2010 Nov-Dec;16(11-12):543-52. doi: 10.2119/molmed.2010.00107. Epub 2010 Aug 27. Review.

2.

Potential role and therapeutic interests of myo-inositol in metabolic diseases.

Croze ML, Soulage CO.

Biochimie. 2013 Oct;95(10):1811-27. doi: 10.1016/j.biochi.2013.05.011. Epub 2013 Jun 10. Review.

PMID:
23764390
3.
4.
5.
6.

D-chiro-inositol in insulin action and insulin resistance-old-fashioned biochemistry still at work.

Larner J.

IUBMB Life. 2001 Mar;51(3):139-48. Review. No abstract available.

7.

Allosteric activation of protein phosphatase 2C by D-chiro-inositol-galactosamine, a putative mediator mimetic of insulin action.

Brautigan DL, Brown M, Grindrod S, Chinigo G, Kruszewski A, Lukasik SM, Bushweller JH, Horal M, Keller S, Tamura S, Heimark DB, Price J, Larner AN, Larner J.

Biochemistry. 2005 Aug 23;44(33):11067-73. Erratum in: Biochemistry. 2005 Nov 22;44(46):15422.

PMID:
16101290
8.

Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance.

Rahimi Y, Camporez JP, Petersen MC, Pesta D, Perry RJ, Jurczak MJ, Cline GW, Shulman GI.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16508-13. doi: 10.1073/pnas.1419104111. Epub 2014 Nov 3.

9.

Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase.

Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L.

J Biol Chem. 1992 Feb 25;267(6):3946-51.

10.

Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome.

Baillargeon JP, Iuorno MJ, Apridonidze T, Nestler JE.

Metab Syndr Relat Disord. 2010 Apr;8(2):127-36. doi: 10.1089/met.2009.0052.

11.

Intracellular mediators of insulin action.

Gottschalk WK, Jarett L.

Diabetes Metab Rev. 1985;1(3):229-59. Review. No abstract available.

PMID:
2873004
12.

Effect of trifluoperazine on the action of insulin in rat adipocytes.

Begum N, Tepperman HM, Tepperman J.

Endocrinology. 1986 Jan;118(1):287-92.

PMID:
3510118
14.

Low-carbohydrate diet alters intracellular glucose metabolism but not overall glucose disposal in exercise-trained subjects.

Cutler DL, Gray CG, Park SW, Hickman MG, Bell JM, Kolterman OG.

Metabolism. 1995 Oct;44(10):1264-70.

PMID:
7476282
15.
16.
17.

The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsia.

Scioscia M, Nigro M, Montagnani M.

J Reprod Immunol. 2014 Mar;101-102:140-7. doi: 10.1016/j.jri.2013.05.006. Epub 2013 Aug 2. Review.

PMID:
23962711
18.

Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.

Nestler JE, Jakubowicz DJ, Iuorno MJ.

J Pediatr Endocrinol Metab. 2000;13 Suppl 5:1295-8. Review.

PMID:
11117673
19.

Insulin mediators from rat skeletal muscle have differential effects on insulin-sensitive pathways of intact adipocytes.

Jarett L, Wong EH, Macaulay SL, Smith JA.

Science. 1985 Feb 1;227(4686):533-5.

PMID:
3917578
20.

Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus.

Mandarino LJ, Consoli A, Kelley DE, Reilly JJ, Nurjhan N.

J Clin Endocrinol Metab. 1990 Dec;71(6):1544-51.

PMID:
2121778

Supplemental Content

Support Center